查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1307346

免疫组织化学市场：副产品（抗体、设备、试剂盒）、用途（诊断、药物测试、法医学）、最终用户 - 俄罗斯-乌克兰衝突、高通货膨胀的累积影响 - 2023-2030 年全球预测

Immunohistochemistry Market by Product (Antibodies, Equipment, Kits), Application (Diagnostics, Drug Testing, Forensic), End-user - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球免疫组化市场预计到2023年将达到26.7726亿美元，年复合成长率为10.81%，预计到2030年将出现惊人的增长，达到54.9944亿美元。

FPNV定位矩阵

FPNV定位矩阵对于评估全球免疫组化市场至关重要。通过检查业务战略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的具体需求做出明智的资讯。这种高级分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场份额分析

市场份额分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、积累和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通胀的累积影响。

5、竞争评估与资讯：对主要企业的市场份额、战略、产品、认证、法规状况、专利状况、製造能力等进行综合评价。

6. 产品开发和创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 免疫组化的全球市场规模和预测是多少？

2.在预测期内，COVID-19对全球免疫组织化学市场的抑制要素和影响有哪些？

3. 在预测期内，全球免疫组织化学市场需要投资哪些产品/细分市场/应用/领域？

4. 全球免疫组化市场的竞争策略是什么？

5. 全球免疫组化市场的技术趋势和法律规范是什么？

6. 全球免疫组化市场主要供应商的市场份额是多少？

7. 哪些型态和战略倡议被认为适合进入全球免疫组化市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 癌症和自身免疫性疾病等慢性疾病在人群中广泛存在。
      • 增加技术先进的 IHC 解决方案的开发和产品核可
      • 药物研发和开发活动的增加
    • 抑制因素
      • 资本集中设置和 IHC 解决方案缺乏特异性
    • 机会
      • 整合製药公司和参与 IHC 开发的参与者之间的合作
      • 对个体化/定制医疗的需求不断增加
    • 任务
      • 对产品故障和缺乏熟练专业人员的担忧
  • 市场趋势
  • COVID-19 的累积影响
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通胀的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范
  • 客户定制

第6章免疫组织化学市场：副产品

  • 抗体
    • 一抗
    • 二抗
  • 装置
    • 幻灯片扫描仪
    • 玻片染色系统
    • 组织微阵列
    • 组织处理系统
  • 成套工具
  • 试剂
    • 封闭血清和试剂
    • 呈色受质
    • 冲淡
    • 固定试剂
    • 组织学染色
    • 有机溶剂
    • 蛋白水解酶
    • 稳定剂

第7章免疫组织化学市场：按用途

  • 诊断
    • 自身免疫性疾病
    • 癌症
    • 心血管疾病
    • 糖尿病
    • 感染疾病
    • 肾臟疾病
  • 药检
  • 法医学

第8章免疫组织化学市场：按最终用户分类

  • 学术研究所
  • CRO
  • 法医学研究所
  • 医院和诊断实验室
  • 製药和生物製药公司

第9章美洲免疫组化市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太免疫组化市场

  • 澳大利亚
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲免疫组化市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市场份额分析：主要企业
  • 竞争情景分析：主要企业

第13章上市公司名单

第14章附录

  • 讨论指南
  • 关于许可和定价
Product Code: MRR-A339DAEFADF4

The Global Immunohistochemistry Market is forecasted to grow significantly, with a projected USD 2,677.26 million in 2023 at a CAGR of 10.81% and expected to reach a staggering USD 5,499.44 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunohistochemistry Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immunohistochemistry Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Antibodies, Equipment, Kits, and Reagents. The Antibodies is further studied across Primary Antibodies and Secondary Antibodies. The Equipment is further studied across Slide Scanners, Slide Staining Systems, Tissue Microarrays, and Tissue Processing Systems. The Reagents is further studied across Blocking Sera & Reagents, Chromogenic Substrates, Diluents, Fixation Reagents, Histological Stains, Organic Solvents, Proteolytic Enzymes, and Stabilizers. The Equipment is projected to witness significant market share during forecast period.

Based on Application, market is studied across Diagnostics, Drug Testing, and Forensic. The Diagnostics is further studied across Autoimmune Diseases, Cancer, Cardiovascular Diseases, Diabetes Mellitus, Infectious Diseases, and Nephrological Diseases. The Drug Testing is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Academic & Research Institutes, CROs, Forensic Labs, Hospitals & Diagnostic Laboratories, and Pharma & Biopharma Companies. The Academic & Research Institutes is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immunohistochemistry Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immunohistochemistry Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunohistochemistry Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunohistochemistry Market?

4. What is the competitive strategic window for opportunities in the Global Immunohistochemistry Market?

5. What are the technology trends and regulatory frameworks in the Global Immunohistochemistry Market?

6. What is the market share of the leading vendors in the Global Immunohistochemistry Market?

7. What modes and strategic moves are considered suitable for entering the Global Immunohistochemistry Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Immunohistochemistry Market, by Product, 2022 vs 2030
  • 4.3. Immunohistochemistry Market, by Application, 2022 vs 2030
  • 4.4. Immunohistochemistry Market, by End-user, 2022 vs 2030
  • 4.5. Immunohistochemistry Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Extensive prevalence of chronic diseases such as cancer and autoimmune diseases among population
      • 5.1.1.2. Development of technologically advanced IHC solutions coupled with rising product approvals
      • 5.1.1.3. Increasing drug discoveries and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive setup and dearth of specificity in IHC solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Merging collaborations between pharmaceutical companies and players involved in IHC development
      • 5.1.3.2. Growing demand for personalized/customized medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns pertinent to product failure and shortage of skilled professionals
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Immunohistochemistry Market, by Product

  • 6.1. Introduction
  • 6.2. Antibodies
    • 6.2.1. Primary Antibodies
    • 6.2.2. Secondary Antibodies
  • 6.3. Equipment
    • 6.3.1. Slide Scanners
    • 6.3.2. Slide Staining Systems
    • 6.3.3. Tissue Microarrays
    • 6.3.4. Tissue Processing Systems
  • 6.4. Kits
  • 6.5. Reagents
    • 6.5.1. Blocking Sera & Reagents
    • 6.5.2. Chromogenic Substrates
    • 6.5.3. Diluents
    • 6.5.4. Fixation Reagents
    • 6.5.5. Histological Stains
    • 6.5.6. Organic Solvents
    • 6.5.7. Proteolytic Enzymes
    • 6.5.8. Stabilizers

7. Immunohistochemistry Market, by Application

  • 7.1. Introduction
  • 7.2. Diagnostics
    • 7.2.1. Autoimmune Diseases
    • 7.2.2. Cancer
    • 7.2.3. Cardiovascular Diseases
    • 7.2.4. Diabetes Mellitus
    • 7.2.5. Infectious Diseases
    • 7.2.6. Nephrological Diseases
  • 7.3. Drug Testing
  • 7.4. Forensic

8. Immunohistochemistry Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutes
  • 8.3. CROs
  • 8.4. Forensic Labs
  • 8.5. Hospitals & Diagnostic Laboratories
  • 8.6. Pharma & Biopharma Companies

9. Americas Immunohistochemistry Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Immunohistochemistry Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Immunohistochemistry Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. IMMUNOHISTOCHEMISTRY MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2022 VS 2030
  • FIGURE 3. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 6. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 7. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. IMMUNOHISTOCHEMISTRY MARKET DYNAMICS
  • FIGURE 9. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. IMMUNOHISTOCHEMISTRY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. IMMUNOHISTOCHEMISTRY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRIMARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SECONDARY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 10. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY SLIDE STAINING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY TISSUE PROCESSING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 17. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY BLOCKING SERA & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CHROMOGENIC SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DILUENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FIXATION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HISTOLOGICAL STAINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ORGANIC SOLVENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PROTEOLYTIC ENZYMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STABILIZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 28. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIABETES MELLITUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY NEPHROLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DRUG TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY CROS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PHARMA & BIOPHARMA COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 67. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 74. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 97. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 104. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 111. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 118. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 125. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 132. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 139. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 146. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 153. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 160. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 167. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 174. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 189. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 196. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 203. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 210. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 217. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 224. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 231. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 238. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 245. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 252. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 259. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 266. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 273. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 280. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 287. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 294. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 301. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 308. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 309. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 310. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 311. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 312. SWITZERLAND IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 315. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 316. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 317. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 318. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 319. TURKEY IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED ARAB EMIRATES IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY ANTIBODIES, 2018-2030 (USD MILLION)
  • TABLE 329. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 330. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY REAGENTS, 2018-2030 (USD MILLION)
  • TABLE 331. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 332. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 333. UNITED KINGDOM IMMUNOHISTOCHEMISTRY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 334. IMMUNOHISTOCHEMISTRY MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 335. IMMUNOHISTOCHEMISTRY MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 336. IMMUNOHISTOCHEMISTRY MARKET LICENSE & PRICING